MEDICAMEQ — Medicamen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Medicamen Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	38.2	208	148	37.6	313
Net Total Accounts Receivable
Net Total Receivables	848	887	789	940	845
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,230	1,634	1,596	1,645	2,237
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	921	918	910	864	841
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,257	2,785	2,946	2,972	3,720
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	727	826	846	782	879
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	792	851	876	841	964
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,465	1,934	2,070	2,131	2,756
Total Liabilities & Shareholders' Equity	2,257	2,785	2,946	2,972	3,720
Total Common Shares Outstanding